Activators of peroxisome proliferator-activated receptor γ have depot- specific effects on human preadipocyte differentiation

Journal of Clinical Investigation

Volumn 100, Issue 12, 1997, Pages 3149-3153

  Adams, Maria ^a   Montague, Carl T ^a   Prins, Johannes B ^a   Holder, Julie C ^b   Smith, Stephen A ^b   Sanders, Louise ^a   Digby, Jan E ^a   Sewter, Ciaran P ^a   Lazar, Mitchell A ^c   Chatterjee, V Krishna K ^a   O'Rahilly, Stephen ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Human adipocyte differentiation; Insulin resistance; Peroxisome proliferator activated receptor; Thiazolidinediones

Indexed keywords

GLYCEROL 3 PHOSPHATE DEHYDROGENASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; ROSIGLITAZONE; THIAZOLIDINE DERIVATIVE; TROGLITAZONE;

ADIPOCYTE; ARTICLE; CELL DIFFERENTIATION; HUMAN; HUMAN CELL; INSULIN RESISTANCE; INSULIN SENSITIVITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PEROXISOME; PRIORITY JOURNAL; PROADIPOCYTE; RECEPTOR AFFINITY; RECEPTOR BINDING; TRANSCRIPTION INITIATION;

EID: 17544396164     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119870     Document Type: Article

References (29)

1. Nolan, J.J., B. Ludvik, P. Beerdsen, M. Joyce, and J. Olefsky. 1944. Improvement in glucose tolerance and insulin resistance in subjects treated with troglitazone. N. Engl. J. Med. 333:1386-1390.
2. Dunaif, A., D. Scott, D. Finegood, B. Quintana, and R. Whitcomb. 1996. The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 81: 3299-3306.
3. Tontonoz, P., E. Hu, R.A. Graves, A.I. Budavari, and B.M. Spiegelman. 1994. mPPARγ2: tissue-specific regulator of an adipocyte enhancer. Genes Dev. 8:1224-1234.
4. Chawla, A., E.J. Schwarz, D.D. Dimaculangan, and M.A. Lazar. 1994. Peroxisome proliferator-activated receptor (PPAR) gamma: adipose-predominant expression and induction early in adipocyte differentiation. Endocrinology. 135:798-800.
5. Berger, J., P. Bailey, C. Biswas, C.A. Cullinan, T.W. Doebber, N.S. Hayes, R. Saperstein, R.G. Smith, and M.D. Leibowitz. 1996. Thiazolidinediones produce a conformational change in peroxisomal-proliferator activated receptor-γ: binding and activation correlate with antidiabetic actions in db/db mice. Endocrinology. 137:4189-4195.
6. Wilson, T.H., J.E. Cobb, D.J. Dowan, R.W. Wiethe, I.D. Correa, S.R. Prakash, K.D. Beck, L.B. Moore, S.A. Kliewer, and J.M. Lehman. 1996. The structure-activity relationship between PPARγ agonism and the antihyperglycemic activity of thiazolidinedioncs. J. Med. Chem. 39:665-668.
7. Kim, J.B., and B.M. Spiegelman. 1996. ADD1/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism. Genes Dev. 10:1096-1107.
8. Cao, Z., R.M. Umek, and S.L. McKnight. 1991. Regulated expression of three C/EBP isoforms during conversion of 3T3-L1 cells. Genes Dev. 5:1538-1552.
9. Wang, X.Z., and D. Ron. 1996. Stress-induced phosphorylation and activation of the transcription factor CHOP (GADD153) by p38 MAP kinase. Science. 272:1347-1349.
10. Tontonoz, P., E. Hu, and B.M. Spiegelman. 1994. Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor. Cell. 79: 1147-1156.
11. 2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation. Cell. 8:813-819.
12. Yu, K., W. Bayona, C.B. Kallen, H.P. Harding, C.P. Ravera, G. McMahon, M. Brown, and M.A. Lazar. 1995. Differential activation of peroxisome proliferator-activated receptors by eicosanoids. J. Biol. Chem. 270:23975-23983.
13. 2 is a ligand for the adipocyte determination factor PPARγ. Cell. 83:803-812.
14. Hu, E., P. Tontonoz, and B.M. Spiegelman. 1995. Transdifferentiation of myoblasts by the adipogenic transcription factors PPARγ and C/EBPα. Proc. Natl. Acad. Sci. USA. 92:9856-9860.
15. Tone, Y., T.M. Collingwood, M. Adams, and V.K.K. Chatterjee. 1994. Functional analysis of a transactivation domain in the thyroid hormone β receptor. J. Biol. Chem. 269:31157-31161.
16. Mayne, L.V., A. Priestley, M.R. James, and J.f. Burke. 1986. Efficient immortalization and morphological transformation of human fibroblasts by transfection with SV40 DNA linked to a dominant marker. Exp. Cell Res. 162: 530-538.
17. Hauner, H., G. Entenmann, M. Wabitsch, D. Gaillard, G. Ailhaud, R. Negrel, and E.R. Pfeiffer. 1989. Promoting effect of glucocorticoids on the differentiation of human adipocyte precursor cells cultured in a chemically defined medium. J. Clin. Invest. 84:1663-1670.
18. Peterson, G.L. 1997. A simplification of the protein assay method of Lowry et al. which is generally more applicable. Anal. Biochem. 83:346-356.
19. Montague, C.T., J.B. Prins, L. Sanders, J.E. Digby, and S. O'Rahilly. 1997. Depot- and sex-specific differences in regional fat distribution. Diabetes. 46:342-347.
20. Adams, M., M.J. Reginato, D. Shao, M.A. Lazar, and V.K.K. Chatterjee. 1997. Transcriptional activation by peroxisome proliferator-activated receptor γ is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site. J. Biol. Chem. 272:5128-5132.
21. Hu, E., J.B. Kim, P. Sarraf, and B.M. Spiegelman. 1996. Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARγ. Science. 274:2100-2103.
22. Bronnegard, M., P. Arner, L. Hellstrom, G. Akner, and J.A. Gustafsson. 1990. Glucocorticoid receptor messenger ribonucleic acid in different regions of human adipose tissue. Endocrinology. 127:1689-1696.
23. Arner, P. 1995. Differences in lipolysis between human subcutaneous and omental adipose tissue. Ann. Med. 27:435-438.
24. Zhang, B., J. Berger, G. Zhou, A. Elbrecht, S. Biswas, S. White-Carrington, D. Szalkowski, and D.E. Moller. 1996. Insulin- and mitogen-activated protein kinase-mediated phosphorylation and activation of peroxisome proliferator-activated receptor γ J. Biol. Chem. 271:31771-31774.
25. Kliewer, S.A., K. Umesomo, D.J. Noonan, R.A. Heyman, and R.M. Evans. 1992. Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors. Nature. 358:771-774.
26. Keller, H., C. Dreyer, J. Medin, A. Mahfoudi, K. Ozato, and W. Wahli. 1993. Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers. Proc. Natl. Acad. Sci. USA. 90:2160-2164.
27. De Vos, P., A.M. Lefebvre, S.G. Miller, M. Guerre-Millo, K. Wong, R. Saladin, L.G. Hamann, B. Staels, M.R. Briggs, and J. Auwerx. 1996. Thiazolidinediones repress ob gene expression in rodents via activation of peroxisome proliferator-activated receptor gamma. J. Clin. Invest. 98:1004-1009.
28. Zhang, B., M.P. Graziano, T.W. Doebber, M.D. Leibowitz, S. White-Carrington, D.M. Szalkowski, P.J. Hey, M. Wu, C.A. Cullinan, P. Bailey, et al. 1996. Down-regulation of the expression of the obese gene by an antidiabetic thiazolidinedione in Zucker diabetic fatty rats and db/db mice. J. Biol. Chem. 271:9455-9459.
29. Vidal-Puig, A., M. Jimenez-Linan, B.B. Lowell, A. Hamann, E. Hu, B. Spiegelman, J.S. Flier, and D.E. Moller. 1996. Regulation of PPARγ gene expression by nutrition and obesity in rodents. J. Clin. Invest. 97:2553-2561.